Journals in Life sciences

1-10 of 942 results in All results

Acta Tropica

ISSN: 0001-706X
5 Year impact factor: 2.7
Impact factor: 2.7

Acta Tropica, is an international journal on infectious diseases that covers public health sciences and biomedical research with particular emphasis on topics relevant to human and animal health in the tropics and the subtropics. Its scope includes the biology of pathogens and vectors, host-parasite relationships, mechanisms of pathogenicity, clinical disease and treatment, and we welcome contributions in basic or applied research in disciplines such as epidemiology, disease ecology, diagnostics, interventions and control, mathematical modeling, public health and social sciences, climate change, parasite and vector taxonomy, host and parasite genomics, biochemistry and immunology and vaccine testing. Contributions may be in the form of original research papers, review articles, short communications, opinion articles, or letters to the Editors. Only manuscripts of high scientific significance and innovation will be considered for publication. Manuscripts of minimal international relevance, case reports, and control strategies at very early inconclusive laboratory stages of development will not be considered for publication. Important Guidelines for Acceptance Editors and the Editorial Board of Acta Tropica provide the following guidelines to help authors prepare manuscripts of high quality that can be considered for publication. Maximize your chances of acceptance by making sure your manuscript: Matches the scientific scope of the journal, Presents results that significantly advance science including innovative new approaches, Meets quality standards of presentation and literature citation, Demonstrates potential health or biomedical impact. The above points are critical for publication of original papers. Be aware Editors carefully evaluate initial manuscript submissions and only those meeting the above criteria will be forwarded to review. If reviewed favorably and the authors seriously address all concerns, than chances of acceptance are increased. Review papers, in addition, are expected to carefully synthesize the literarture and make recommendations to advance respective scientific fields. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

The American Journal of Human Genetics

ISSN: 0002-9297
5 Year impact factor: 11.8
Impact factor: 9.8

AJHG provides a record of research and review relating to heredity in humans and to the application of genetic principles in medicine and public policy, as well as in related areas of molecular and cell biology. Topics explored by AJHG include behavioral genetics, biochemical genetics, clinical genetics, cytogenetics, dysmorphology, gene therapy, genetic counseling, genetic epidemiology, genomics, immunogenetics, molecular genetics, neurogenetics, and population genetics. AJHG welcomes submissions of articles and reports on timely subjects concerning all aspects of human genetics, including studies of model organisms that are of direct relevance to human genetics. Manuscripts should be written in a manner accessible to investigators representing diverse backgrounds in human genetics. Descriptions of new statistical methods of general interest to the genetics community are welcome. New methods should be compared to existing methods with the use of real data and/or simulations with parameters (e.g., haplotype frequencies, effect sizes) that are based on a real data example (e.g., marker or haplotype data from the HapMap project). All novel computer programs must be made publicly available by the time that the manuscript is published, and a URL for the website must be included in the Web Resources section of the manuscript. Letters commenting on material previously published in AJHG are also welcome. AJHG does not publish reports of either single mutations or mutational surveys of previously identified loci unless they have unusual significance and substantial insight. Descriptions of new linkage assignments will be considered only if they are of special interest. Reports of negative data will not normally be considered. Visit the Cell Press website for more information about AJHG - http://www.cell.com/AJHG/home

Analytical Biochemistry

ISSN: 0003-2697
5 Year impact factor: 3.2
Impact factor: 2.9

Methods in the Biological Sciences The journal's title Analytical Biochemistry: Methods in the Biological Sciences declares its broad scope: methods for the basic biological sciences that include biochemistry, molecular genetics, cell biology, proteomics, immunology, bioinformatics and wherever the frontiers of research take the field. The emphasis is on methods from the strictly analytical to the more preparative that would include novel approaches to protein purification as well as improvements in cell and organ culture. The actual techniques are equally inclusive ranging from aptamers to zymology. The journal has been particularly active in: Analytical techniques for biological molecules Aptamer selection and utilization Biosensors Chromatography Cloning, sequencing and mutagenesis Electrochemical methods Electrophoresis Enzyme characterization methods Immunological approaches Magnetic resonance spectroscopy (in vivo) Mass spectrometry of proteins and nucleic acids Metabolomics Nano level techniques Optical spectroscopy in all its forms The journal is reluctant to include most drug and strictly clinical studies as there are more suitable publication platforms for these types of papers. Apart from full-length original research papers, the journal also welcomes Review papers, and Notes and Tips - featuring methods that can be summarized in a shorter format article, including helpful "kitchen tricks".

Animal Behaviour

ISSN: 0003-3472
5 Year impact factor: 2.8
Impact factor: 2.5

Animal Behaviour is published for the Association for the Study of Animal Behaviour in collaboration with the Animal Behavior Society. First published in 1953, Animal Behaviour is a leading international publication and has wide appeal, containing critical reviews, original papers, and research articles on all aspects of animal behaviour. Book Reviews and Books Received sections are also included. Growing interest in behavioural biology and the international reputation of Animal Behaviour prompted an expansion to monthly publication in 1989. Animal Behaviour continues to be the journal of choice for biologists, ethologists, psychologists, physiologists, and veterinarians with an interest in the subject. Research Areas include: • Behavioural ecology • Evolution of behaviour • Sociobiology • Ethology • Behavioural psychology • Behavioural physiology • Population biology • Sensory behaviour • Navigation and migration

Archives of Biochemistry and Biophysics

ISSN: 0003-9861
5 Year impact factor: 4
Impact factor: 3.9

ABB: Publishing great science for over 75 years! Archives of Biochemistry and Biophysics publishes quality original articles and reviews in the developing areas of biochemistry and biophysics. The focus of the journal is on studies that significantly advance mechanism. Scientifically valid reports of studies that do not advance the understanding of the underlying mechanism of the system under study are unlikely to be accepted. Research Areas Include:• Enzyme and protein structure, function, regulation. Folding, turnover, and post-translational processing • Biological oxidations, free radical reactions, redox signaling, oxygenases, P450 reactions • Signal transduction, receptors, membrane transport, intracellular signals. Cellular and integrated metabolism.Benefits to authors We also provide many author benefits, such as, a liberal copyright and posting policy, special discounts on Elsevier publications, and much more Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biochimica et Biophysica Acta: Bioenergetics

ISSN: 0005-2728
5 Year impact factor: 4.1
Impact factor: 4.3

BBA Bioenergetics covers the area of biological membranes involved in energy transfer and conversion. In particular, it focuses on the structures obtained by X-ray crystallography and other approaches, and molecular mechanisms of the components of photosynthesis, mitochondrial and bacterial respiration, oxidative phosphorylation, motility and transport. It spans applications of structural biology, molecular modeling, spectroscopy and biophysics in these systems, through bioenergetic aspects of mitochondrial biology including biomedicine aspects of energy metabolism in mitochondrial disorders, neurodegenerative diseases like Parkinson's and Alzheimer's, aging, diabetes and even cancer. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biochimica et Biophysica Acta: Bioenergetics

Biochimica et Biophysica Acta: Biomembranes

ISSN: 0005-2736
5 Year impact factor: 3.5
Impact factor: 3.4

BBA Biomembranes has its main focus on membrane structure, function and biomolecular organization, membrane proteins, receptors, channels and anchors, fluidity and composition, model membranes and liposomes, membrane surface studies and ligand interactions, transport studies, and membrane dynamics. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biochimica et Biophysica Acta: Biomembranes

Biochemical and Biophysical Research Communications

ISSN: 0006-291X
5 Year impact factor: 3.2
Impact factor: 3.1

Biochemical and Biophysical Research Communications (BBRC) is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. For short communication papers, we offer the fastest submission to acceptance of any journal within life sciences, with "accept" decisions rendered within three weeks of submission. We will now consider full-length research papers and review articles. The journal covers most of areas of life science, and is divided into the following sections: Biochemistry Biophysics Cell Biology Cellular Pathology and Cancer Computational Biology and Bioinformatics Genetics Immunology and Inflammation Microbiology and Virology Nanomedicine and Bionanomaterials Neuroscience Pharmacology Physiology Plant Biology Structural Biology Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center. Announcement: BBRC has traditionally only published short communications of novel results. From 2023, the journal now publishes short communications, full-length research papers, and reviews. What type of paper should I choose on submission? For short communications, we will still aim to make an accept or reject decision within two weeks of submission. If you have novel results that you can consolidate into 4,600 words, with no more than four figures, then you may continue to choose the short communication route. Short communications should be concise, no more than 4,600 words and up to four display items. They should offer novel insights and warrant a rapid peer review process. The 4,600 word count includes the title page, all sections of the manuscript (including the references), and the figure and table legends. Papers that exceed these limits will be reassigned within the submission system as a full-length research paper. If you submit a full-length research paper or a review paper, we will continue to offer a fast turnaround (with a decision after review within 30 days of submission), and we'll also make sure that any revisions that we request of you will not require significant resource expenditure on your part. Full-length research papers should present a comprehensive account of original research. These papers are not restricted by length or number of figures. Review papers should be authoritative, state-of-the-art accounts of the selected research field and be of high interest, balanced, and accurate. Beyond summaries of important scientific developments and ideas, authors are encouraged to identify and discuss how the field may be impacted or develop in the future, including insights that may be of significance to the scientific community. The number of co-authors of review articles is limited to five, and each author is expected to make a substantial contribution to the writing of the manuscript. There are no restrictions on length for review papers, and we welcome both comprehensive reviews and short reviews that offer an insight into more recent advances in a field.

Biochemical Pharmacology

ISSN: 0006-2952
5 Year impact factor: 5.8
Impact factor: 5.8

Biochemical Pharmacology publishes original research findings and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics. The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process. All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complementary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review. While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy. Reports describing experiments conducted with natural product mixtures, plant or animal extracts will not be considered for publication unless the structures and concentrations of all component substances are known, and the agents can be easily obtained by others wishing to replicate the study. The chemical structure of all novel compounds tested must be included in the submitted manuscript or be readily accessible in the published literature. References to structures in the patent literature must unambiguously identify a single molecular structure. All compounds, reagents, instrumentation and equipment employed in a study must be available from identified commercial suppliers, bio/pharmaceutical companies or from individuals holding legal rights to their use. Submissions will not be considered for publication if the chemical structures of tested compounds are not revealed, generally known, or accessible in the literature. Original research submissions must contain: A rationale for the selection of the compound/drug for study as well as for the concentrations/doses employed. Quantities used for concentration- and dose-response experiments should vary logarithmically, e.g., 1, 3, 10, 30 mg/kg, 0.1, 1.0, 10, 100 nanomolar, etc. Justification must be provided for studying only a single concentration or dose of a compound, especially as it relates to reference standards and antagonists/modulators of receptors, enzymes and signaling pathways. Justification must also be provided for the selection of the statistical tests employed as they relate to the experimental design. It is expected that all findings have been subjected to rigorous quantitative analyses, with the calculation and reporting of IC50, Ki, EC50, etc., values. These must be derived from a minimum of three (3) separate and distinct experiments, with the replicates within any single experiment being averaged to obtain a single value for that experimental series. Manuscripts that fail to meet these criteria will be subject to rejection without peer-review. US National Institutes of Health (NIH) voluntary posting ("Public Access") policy Biochemical Pharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy. Please bookmark this URL: https://www.elsevier.com/locate/biochempharm Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biological Psychiatry

ISSN: 0006-3223
5 Year impact factor: 11.9
Impact factor: 10.6

A journal of Psychiatric Neuroscience and TherapeuticsA Publication of the Society of Biological Psychiatry AIMS AND SCOPE Biological Psychiatry, founded in 1969, is an official journal of the Society of Biological Psychiatry and the first in the Biological Psychiatry family of journals. Companion titles include Biological Psychiatry: Cognitive Neuroscience and Neuroimaging and Biological Psychiatry: Global Open Science. The Society's purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, and behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes novel results of original basic, translational, and clinical mechanistic research that advances our understanding of psychiatric disorders and their treatment. Reviews and commentaries that focus on topics of current research and interest are also encouraged. Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. The 2022 Impact Factor score for Biological Psychiatry is 10.6. In the 2022 Journal Citation Reports published by Clarivate Analytics, it is ranked 12th out of 155 Psychiatry titles and 17th out of 272 Neurosciences titles, by Impact Factor. By total citations, Biological Psychiatry is ranked 2nd in Psychiatry. It is also the 5th ranked journal in Psychiatry according to Google Scholar (July 2022). Biological Psychiatry's acceptance rate is less than 10%. The average time from submission to first decision is less than 20 days, with an editorial rejection (reject without peer review) decision issued within 5 days. Accepted articles are published online, prior to copyediting, within one week of final acceptance, with the corrected proof later replacing that version. Articles are generally published in print 6-8 months after acceptance. More information about the journal and the Society of Biological Psychiatry is available through links on this page. In addition to offering the finest reports in psychiatric neuroscience today, we hope to bring the journal's information to you in the most user-friendly and easily accessible manner. Therefore, your feedback is welcome at [email protected]. No responsibility is assumed by the Publisher or by the Society of Biological Psychiatry for any injury and/or damages to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. No suggested test or procedure should be carried out unless, in the reader's judgment, its risk is justified. Because of rapid advances in the medical sciences, we recommend the independent verification of diagnoses and drug dosages. Discussions, views, and recommendations as to medical procedures, choice of drugs, and drug dosages are the responsibility of the authors.